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Alopecia areata (AA) is an autoimmune disease that targets actively growing (anagen) hair follicles in humans and
other mammals. C3H/HeJ, but not C57BL/6J, mice spontaneously develop an adult-onset form of AA. A segregating
population of C3HB6F2 female mice (n¼ 1096), generated from crossing these two strains, was used for genome-
wide linkage analysis to identify AA genetic susceptibility. Previous analysis identiﬁed susceptibility intervals on
chromosomes 17 (Alaa1) and 9 (Alaa2). Using additional markers in these intervals and saturation mapping
purported intervals on chromosomes 8 and 15, two additional regions were identiﬁed (Alaa3 and Alaa4,
respectively). Human gene association studies identiﬁed speciﬁc human leukocyte antigen intervals comparable
with those (major histocompatibility complex) found in Alaa1 in the mouse. Other human studies identiﬁed genes
not found in this linkage study, but these human transcription factors are directly regulated by genes within Alaa1.
These results indicate the necessity of integrating both gene association and genome-wide linkage studies in both
mice and humans to understand the complex nature of these and other polygenic diseases.
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Alopecia areata (AA) in humans is an autoimmune disease
that targets hair follicles in the actively growing anagen
stage. It can affect nearly 2% of the general population
(Safavi et al, 1995). AA is associated with a heterogeneous
phenotype (Whiting, 2001, 2003). By contrast, rodent
models on inbred strain backgrounds that make them
essentially genetically identical, when raised in controlled,
pathogen-free environments, provide relatively mono-
morphic models to dissect subtypes of this complex
disease. Mouse models are especially useful for investigat-
ing complex genetic questions.
The C3H/HeJ inbred laboratory mouse spontaneously
develops an adult-onset form of an AA-like disease that is
very similar to adult-onset human AA (Sundberg et al, 1994,
2004). Initial analysis of an intercross using these mice with
another strain resistant to developing AA identified sig-
nificant genomic intervals containing AA susceptibility
genes on mouse chromosomes (m. chr.) 17, which was
highly significant, and 9, which was marginally significant
(Sundberg et al, 2003). These intervals were subsequently
assigned the designation Alaa1 and Alaa2 for ALopecia
AreatA, respectively, by the International Mouse Nomen-
clature Committee. Alaa1 includes H2 (human HLA ortho-
log), tumor necrosis factor alpha (Tnfa), and lymphotoxin
alpha and beta (Lfta, Lftb). Alaa 2 contains genes that code
for proteins involved with T cell function (Cd3, Thy1, and
regulatory T cell molecule, Ctram), cytokines that regulate
inflammation (Il10ra) or neural cell adhesion molecule
(Ncam1). Many human gene association studies have found
HLA linkage to AA (Duvic et al, 1991, 1995; Morling et al,
1991; Welsh et al, 1994; Colombe et al, 1995a, b, 1999;
deAndrade et al, 1999, 2001; Kavak et al, 2000) making the
mouse Alaa1 interval, which contains the homologous
group of genes, an important focus and supports the value
of this mouse model for AA.
Expanding the initial study, we refined the statistics for
Alaa1 and 2 and also identified significant intervals on m.
chr. 8 (Alaa3) and 15 (Alaa4). A variety of immunoregulatory
genes are located within these intervals providing new
candidates for analysis of genes responsible for suscept-
ibility for AA.
Results
The frequency of F2 mice developing AA and characteriza-
tion of the disease phenotype were described previously
(Sundberg et al, 2003, 2004). Initial statistical analysis for
Alaa1 (LOD score 10.9) and Alaa2 (LOD score 2.0) changed
slightly (Table I) but the intervals remained the same (Fig 1A
and B). Two new intervals with significant linkage were
identified. Alaa3, located on m. chr. 8 (LOD score 2.411) and
Alaa4, on m. chr. 15 (LOD score 2.815) were identified (Table
I). Many of the homologous human genes are located on h.
chr 4 and 8, respectively (Fig 1B and D). All four intervals
contain numerous immunoregulatory genes that may have
important direct or indirect effects on the onset and course
of AA in mammals.
Abbreviations: AA, alopecia areata; Aire, autoimmune regulator
gene; Alaa1-4, Alopecia areata locus 1-4; H2, mouse major
histocompatibility locus; HLA, human leukocyte antigen; LOD,
logarithm of odds ratio; m. chr, mouse chromosome
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Discussion
Identification of four unlinked large genetic intervals, several
of which have more than one distinct peak, suggest that
four or probably many more genes are involved with
susceptibility and progression of AA in the C3H/HeJ mouse
model. The intervals are still too large to focus on specific
genes; however, based on known function several should
be considered. For Alaa3 on m. chr. 8, genes that might play
a direct or indirect role in AA, including Janus kinase 3
(JAK3), interleukin 12 receptor beta 1 (IL12RB1), and inter-
leukin 15 (IL15) as well as a gene involved with apoptosis
(caspase 3, CASP3), are highlighted in Fig 1A. Within the
two significant peaks containing Alaa4 on m. chr. 15 are a
number of potential candidate genes including those
involved in immunoregulation (interleukin 2 receptor beta
chain, IL2rb; lymphocyte antigen 6 complex, locus D,
mouse Ly6d, or human E48), pigment migration (a disin-
tegrin-like and metalloprotease with thrombospondin type 1
motif 20, ADAMTS20, and SRY-box containing gene 10,
SOX10), skin integrity (trichorhinophalangeal syndrome 1,
TRPS1; plectin 1, Plec1), or thyroid function (thyrotropin
releasing factor hormone receptor, TRHR) as highlighted in
Fig 1C (Mouse Genome Informatics, 2003). Thyroid abnor-
malities have been associated with a subpopulation of
human AA patients (McElwee et al, 1998b).
Regrowth of unpigmented (white) hair in both mice and
humans with AA has long been thought to be secondary to
autoimmune targeting of melanin or melanin-related pro-
teins or a sequela to injury to the hair follicle itself (Sundberg
et al, 2004). Two genes located within the mouse AA
susceptibility intervals (ADAMTS20 and SOX10), mutations
of which result in failure of normal pigment migration into
hairs (Mayer and Maltby, 1964; Lane and Liu, 1984) provide
an interesting alternative genetic-based hypothesis that
should be considered, namely, genetic-based abnormal
pigment migration into hair follicles and fibers.
Human AA genetic studies have largely focused on gene
associations, where a specific gene or group of genes are
hypothesized to be linked with the disease, and only now
are genomic linkage studies being initiated (Martinez-Mir
et al, 2003), where a random genome-wide screen is
performed to search for linkage. The most recent gene
association studies identified specific polymorphisms in the
autoimmune regulator (AIRE) and notch 4 (NOTCH4) genes
(Tazi-Ahnini et al, 2002, 2003). Targeted mutations of these
mouse genes, on the B6;129 segregating background, do
not develop AA (Krebs et al, 2000; Anderson et al, 2002;
Ramsey et al, 2002). All of these targeted mutant mice have
AA resistance haplotypes within the m. chr. 17 interval,
based on our C3HB6F2 intercross study (Sundberg et al,
2003), which may account for the lack of an inflammatory
skin or hair (alopecia) phenotype. The mouse Aire gene,
located on m. chr. 10, is not located within any area of
susceptibility identified in our gene mapping study, whereas
Notch4 is between several susceptibility candidate genes
including H2k, Tnf, Lta, and Ltb on m. chr. 17, all of which
are within Alaa1, the interval with the highest logarithm of
odds ratio (LOD) score. Recently, lymphotoxin alpha (Lta)
and beta (Ltb) were shown to regulate directly Aire (Chin
et al, 2003). Furthermore, Aire is a transcription factor that
affects other genes not associated with AA (Ramsdell and
Ziegler, 2003) in either linkage or gene association studies,
further expanding candidate genes worth investigating
related to AA susceptibility. Congenic strains are being
created to add various C3H susceptibility intervals to the
genomes containing null mutations in either Aire or Notch4
or both genes to determine their significance, if any, in the
pathogenesis of AA. The new mapping data provided here
expand the genomic intervals for AA susceptibility candi-
date genes. Integration of information from human gene
association and linkage studies, mouse linkage studies, and
basic immunological research reveals the complex interac-
tion of genes in this and other autoimmune diseases and
points to the importance of approaching these problems
from a variety of directions, since no one method by itself is
able to define these complex polygenic diseases.
Materials and Methods
Mice Female C3H/HeJ mice that spontaneously developed AA
and clinically normal C57BL/6J males that never develop AA,
obtained from The Jackson Laboratory (Bar Harbor, Maine), were
intercrossed to generate C3HB6F2 mice. The mouse work was all
reviewed and approved by our institutional animal care and use
committee. These animals were followed until 15 mo of age. A total
of 1096 F2 female mice were observed for development of
alopecia. One hundred and thirty eight mice developed clinical
Table I. Analysis of variance (ANOVA) of a multiple regression model using all the signiﬁcant loci detected in the
C3H/HeJ mouse alopecia areata model
Chr. Locus Peak (cM) df Type III SS LOD % Var. F-value P (f)
8 Alaa3 32 2 2.133 2.411 2.427 5.499 0.004443
9 Alaa2 20 2 1.889 2.139 2.149 4.869 0.008195
15 Alaa4 28 2 2.475 2.791 2.815 6.379 0.001896
17 Alaa1 16 2 9.626 10.346 10.949 24.814 8.09  1011
Total 366 87.92
df, degrees of freedom; Type III SS, sum of square with adjustment to the mean value of the phenotype; LOD, maximum LOD score at the peak of each
quantitative trait locus (QTL); % Var., percentage of phenotypic variance explained by each QTL; F-value, mean square (Type III SS/df) of a QTL divided
by mean square of error term (df¼ 358).
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AA that was confirmed by histopathology (Sundberg et al, 1994).
These 138 mice with AA, along with 214 clinically normal litter-
mates, were subjected to genome-wide screens.
Mice were maintained in a humidity-, temperature-, and light
cycle (12:12)-controlled conventional animal facility (Sundberg et al,
1994; McElwee et al, 1998a). Mice were caged, four per side, in
Figure 1
Fine mapping of m.Chr.8 (Alaa3, A), 9 (Alaa2, B), 15 (Alaa4, C), and 17 (Alaa1, D), at 2 cM intervals, identified susceptibility intervals involved in
mouse alopecia areata (AA). Logarithm of odds ratio (LOD) score is the solid line while posterior probability density score is the dotted line. Based on
a permutation test (Churchill and Doerge, 1994), LOD scores of 1.8 or 2.2 correspond to a p-value of 0.10 and 0.05, respectively. Location and
symbols for homologous human genes within the susceptibility intervals are potential candidate genes (bold type), and locations of the markers with
the peak LOD score for each interval (gray box) are indicated. Map modified from The Jackson Laboratory Mouse Genome Informatics website
(www.informatics.jax.org).
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double-pen polycarbonate cages (330 cm2 floor area). They
received autoclaved food (NIH diet 31, 6% fat) and acidified water
(pH 2.8–3.2) ad libitum.
Genotyping DNA was isolated from amputated tail tips and
extracted using a DNeasy kit (Qiagen, Velencia, California). DNA
were genotyped by PCR using microsatellite markers purchased
from Invitrogen (www.invitrogen.com). The Jackson Laboratory’s
allele typing service also provided multiplex genotyping data by
using ABI 370 instrumentation (http://jaxmice.jax.org). This study
utilized 219 informative markers. The list of markers is available on
request. Linkage maps and marker positions reported are based
on The Jackson Laboratory’s online Mouse Genome Informatics
resource (www.informatics.jax.org).
Statistical analysis Genome scans were carried out by using
both marker regression and interval mapping analysis. Because
similar results were obtained using both methods, only the results
of interval mapping are presented. LOD scores for main effects
were computed at 2 cM intervals across the autosomal genome,
and LOD scores for pairwise scans were calculated at 5 cM
resolution. The interpretation of results was simplified by focusing
on the individual trait of AA versus clinical normality. Pairwise
interactions among loci were assessed using genome-wide scans
(Sen and Churchill, 2001, Sugiyama et al, 2001). The significance of
a pair of loci was assessed first by using an overall F test (with 8
and 399 degrees of freedom) for a two-way ANOVA model of
genotypic effects. When this test exceeded the genome-wide
threshold as established by permutation analysis, secondary tests
were carried out to test for an interaction effect. If an interaction
was indicated, testing was stopped and an interacting pair was
declared. If no significant evidence for interaction was uncovered,
each of the single models was compared with the two additive
model. Both tests must be significant to indicate an additive pair.
These secondary tests were carried out at a nominal 0.005 level to
account for testing of more than one but fewer than 10 potential
pairs. All software used in this analysis are available at www.jax.
org/research/churchill.
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